avalotx.com (AVTX) - Bozor qiymatining balans qiymatiga nisbati
Avalo Therapeutics, Inc (AVTX) autoimmun patologiyalar va kam uchraydigan yallig'lanish kasalliklari uchun terapiya vositalarini bozorga olib chiqish orqali daromad keltiradi. GURU.Markets platformasidagi ushbu narxlar grafigi joriy tendentsiyani tasdiqlaydi, bunda ko'rsatkich 0.89 darajasida turibdi. Biznes muvaffaqiyati klinik sinovlardan muvaffaqiyatli o'tish va "orphan drug" (kam uchraydigan kasalliklar dori vositasi) maqomini olishga bog'liq. Biroq, strategiyaning o'zgarishi va likvidlik tanqisligi aktivni spekulyativ qiladi, bu esa yangi aksiyalar emissiyasi yoki hamkorlarga qaramlikni yuzaga keltiradi.
Avalo Therapeutics, Inc. (AVTX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Avalo Therapeutics, Inc|AVTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics Inc.|AVTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Avalo Therapeutics, Inc|AVTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Avalo Therapeutics|Tezkor likvidlik koeffitsiyenti avalotx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Avalo Therapeutics, Inc - AVTX
Ushbu koeffitsient aktivlarning joriy bozor qiymatini ularning haqiqiy balans qiymatiga solishtiradi va bozor kompaniyani uning kapitaliga nisbatan qanchalik hadda qimmat baholaganini ochib beradi. Avalo Therapeutics, Inc (AVTX) uchun narxning balans qiymatiga nisbati (P/B) tahlil qilinganda, barqaror daromadning yo'qligini hisobga olish juda muhimdir, chunki bu investitsiya profilini spekulyativ va klinik sinovlar natijalariga bog'liq qiladi.
Raqobatchilar tahlili
ARGX (argenx SE) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati BNTX|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS (Astria Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|ENGN (engene.com) - Bozor qiymatining balans qiymatiga nisbati|RAPT (RAPT Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Aerovate|Bozor qiymatining balans qiymatiga nisbati Aclaris (ACRS)|Bozor qiymatining balans qiymatiga nisbati KYTX (Kyverna Therapeutics, Inc)|Bozor qiymatining balans qiymatiga nisbati Tiziana Life Sciences TLSA|cabalettabio.com (CABA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|VTYX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati THTX (Theratechnologies, Inc.)|ELDN (Eledon) - Kapitallashuvning sof aktivlarga nisbati|AGEN: Bozor kapitallashuvining balans qiymatiga multiplikatori|CLYM (Climb Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|ZURA: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ATYR|ADAG - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Ikena Oncology IMA|Balans qiymatiga nisbatan bozor qiymati STTK|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|CNTB - Bozor kapitallashuvining balans qiymatiga nisbati|immunic-therapeutics.com (IMUX) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ATRA (Atara Bio)|IFRX (InflaRx NV) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti X4 Pharmaceuticals, Inc XFOR|Kapitallashuvning sof aktivlarga nisbati ACET (Adicet Bio)|Bozor kapitallashuvining balans qiymatiga nisbati celularity.com (CELU)|INmune Bio - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori BRNS (Barinthus Biotherapeutics PLC)|Kezar Life Sciences, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SAB Biotherapeutics Inc SABS|AKTX: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Enlivex Therapeutics Ltd.|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc|GeoVax Labs (GOVX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati EDSA (Edesa)|IBIO (iBio Corporation) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi xtlbio.com (XTLB)|BOLT - Bozor qiymatining balans qiymatiga nisbati|HCWB (HCW Biologics Inc.) - Kapitallashuvning balans qiymatiga nisbati|APVO: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati aimimmuno.com|ADTX (Aditxt Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati gribio.com|Kapitallashuvning sof aktivlarga nisbati XRTX (XORTX Therapeutics)|Bozor qiymatining balans qiymatiga nisbati HIND (Vyome Holdings Inc.)|Revelation Bio - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori INDP (Indaptus Corp)|SCNI: Kapitallashuvning sof aktivlarga nisbati|CALI (CalciMedica, Inc.) - Kapitallashuvning balans qiymatiga nisbati|affimed.com (AFMD) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ALLK (Allakos)|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|IGMS: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati oceanbiomedical.com (OCEA)|Bozor qiymatining balans qiymatiga nisbati TC BioPharm TCBP|Balans qiymatiga nisbatan bozor qiymati THRD